SC 13D/A

AMENDMENT NO. 12 TO SCHEDULE 13D

Company: Lineage Cell Therapeutics, Inc.
Filed: October 9, 2003
Accession Number: 0000950149-03-002305

View Document ↗ View on SEC.gov ↗